Message

On Tuesday October 24th between 7am and 9am, we will carry out scheduled maintenance of the network. During this period of time, there may be potential outages, and the repository may be unavailable.

Thank you for your attention. We apologise for any inconvenience caused.

Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway

Porakishvili, N., Kardava, L., Jewell, A.P., Yong, K., Glennie, M.J., Akbar, A. and Lydyard, P.M. (2004) Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Haematologica, 89(4), pp. 435-443. ISSN (print) 0390-6078

Full text not available from this archive.

Abstract

BACKGROUND AND OBJECTIVES: B-cell chronic lymphocytic leukemia (B-CLL) is a clonal expansion of CD5+B cells that accumulate due to their uncontrolled growth and resistance to apoptosis. We have previously shown that up to 50% of blood CD4+ T cells in B-CLL patients have a cytotoxicity-related CD28- CD57+ phenotype and high content of both granzyme B and perforin (PF). In this study we investigate the cytotoxic potential of these cells against autologous B-CLL cells. DESIGN AND METHODS: Blood CD4+ or CD8+ T cells were positively isolated from B-CLL patients and cultured under a range of conditions with autologous purified B-CLL cells and with bispecific [anti-CD3 x anti-CD19] antibodies. Apoptosis of labeled B-CLL cells was assessed using the change of mitochondrial membrane potential with the fluorescent dye DiOC6 and confirmed by annexin V binding. RESULTS: There was time- and dose-dependent killing of B-CLL cells by both CD8+ and CD4+ T cells and this ranged from 6.6 - 68.0% for CD4+ cells and 6.4 - 57.8% for CD8+ cells. Almost complete inhibition by concanamycin A suggests that CD4+ T cells like CD8+ T cells induced apoptosis through a perforin-mediated pathway, but not via Fas/FasL (as indicated by lack of blocking with brefeldin A), tumor necrosis factor alpha or TRAIL. INTERPRETATION AND CONCLUSIONS: This study shows that blood CD4+PF+ T cells enriched in B-CLL patients, are able to kill autologous B-CLL cells ex vivo, through bispecific antibodies via a perforin mediated mechanism.

Item Type: Article
Additional Information: This work was supported by Special Trustees of the Middlesex Hospital, UCH and Royal Free & UCL Medical School and INTAS [grant number EU 2239].
Uncontrolled Keywords: b-cll, cd4-cytotoxicity, perforin, in-vitro, cytokine production, dendritic cells, effector-cells, ex-vivo, apoptosis, mechanism, responses, immunotherapy, concanamycin
Research Area: Allied health professions and studies
Faculty, School or Research Centre: Faculty of Health and Social Care Sciences (until 2013)
Related URLs:
Depositing User: Lucinda Lyon
Date Deposited: 04 Jul 2008
Last Modified: 28 Jun 2010 11:54
URI: http://eprints.kingston.ac.uk/id/eprint/1075

Actions (Repository Editors)

Item Control Page Item Control Page